Holen Sie sich die Stockscreener-App
21.62
1.95%
-0.43
Catalyst Pharmaceuticals Inc Aktie (CPRX) Neueste Nachrichten
Cautious Investors Not Rewarding Catalyst Pharmaceuticals, Inc.'s (NASDAQ:CPRX) Performance Completely - Simply Wall St
Allspring Global Investments Holdings LLC Boosts Stake in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - MarketBeat
Catalyst Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Given Average Recommendation of "Buy" by Brokerages - MarketBeat
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Stake Raised by Allspring Global Investments Holdings LLC - Defense World
Catalyst Pharmaceuticals (CPRX) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat
Allspring Global Investments Holdings LLC Has $8.71 Million Holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - Defense World
Catalyst Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Catalyst Pharmaceuticals stock hits all-time high of $24.44 - MSN
Those who invested in Catalyst Pharmaceuticals (NASDAQ:CPRX) five years ago are up 374% - Yahoo Finance
Yousif Capital Management LLC Has $903,000 Stock Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - Defense World
Advisors Preferred LLC Takes $1.08 Million Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - MarketBeat
Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2024 Financial Results on February 26, 2025 - GlobeNewswire
Catalyst Pharmaceuticals to Announce Fourth Quarter and Full-Year 2024 Financial Results on February 26, 2025 - Nasdaq
Earnings Alert: Catalyst Pharmaceuticals Sets Key Q4 Financial Results DateStrategic Updates Expected - StockTitan
abrdn plc Acquires Shares of 484,666 Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - MarketBeat
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Shares Bought by Spire Wealth Management - MarketBeat
Catalyst Pharmaceuticals (NASDAQ:CPRX) Raised to "Strong-Buy" at Baird R W - MarketBeat
Short Interest in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Rises By 12.5% - MarketBeat
Catalyst Pharmaceuticals (NASDAQ:CPRX) Coverage Initiated by Analysts at Robert W. Baird - MarketBeat
Catalyst Remains a Big Money Favorite - FX Empire
Robert W. Baird Initiates Coverage on Catalyst Pharmaceuticals (NASDAQ:CPRX) - Defense World
Catalyst Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch
Baird Initiates Coverage of Catalyst Pharmaceuticals (CPRX) with Outperform Recommendation - MSN
Baird starts Catalyst Pharma with Outperform, $28 target - MSN
This Expand Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga
Baird Initiates Coverage on Catalyst Pharmaceuticals With Outperform Rating, $28 Price Target - Marketscreener.com
Beyond The Numbers: 6 Analysts Discuss Catalyst Pharmaceuticals Stock - Benzinga
SG Americas Securities LLC Buys 24,102 Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - MarketBeat
Catalyst Pharmaceuticals (NASDAQ:CPRX) Stock Price Up 5.4%Time to Buy? - MarketBeat
Catalyst Pharmaceuticals (NASDAQ:CPRX) Hits New 12-Month HighWhat's Next? - MarketBeat
CPRX: 3 Niche Healthcare Stocks Tackling Rare Diseases - StockNews.com
Nilsine Partners LLC Invests $700,000 in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - MarketBeat
Moody Aldrich Partners LLC Trims Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - MarketBeat
EMC Capital Management Has $308,000 Stock Holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - MarketBeat
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Shares Bought by SG Americas Securities LLC - Defense World
Catalyst Pharmaceuticals stock hits all-time high of $24.44 By Investing.com - Investing.com Australia
0.27%
3.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):